{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:46:10Z","timestamp":1782726370898,"version":"3.54.5"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CBF2023-2024-109"],"award-info":[{"award-number":["CBF2023-2024-109"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Direcci\u00f3n General de Apoyo al Personal Acad\u00e9mico"},{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["IN222626"],"award-info":[{"award-number":["IN222626"]}],"id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite the landmark discovery of the hepatitis E virus (HEV) four decades ago and its status as the leading cause of viral hepatitis worldwide, the infection remains overlooked in numerous countries. Currently, there are no approved treatments for hepatitis E or licensed vaccines available for global distribution. The clinical presentation of infection is influenced by the host's immune response and may also be affected by metabolic factors. We previously reported an immunomodulatory role for conjugated bilirubin (cBR) in hepatitis A virus infection, and antiviral effects of this metabolite have been proposed. However, the impact of cBR on HEV infectivity and the mechanisms underlying this effect have yet to be elucidated. By combining (i) ex vivo analysis of HEV-infected patients, (ii) in vitro antigenic restimulation of peripheral blood mononuclear cells (PBMCs) cultured with different cBR doses, and (iii) in vitro infection of permissive cell lines, we found that cBR concentrations of 2\u2005mg\/dL lowered viral titers and increased IFN-\u03b3 release in patients with acute infection. Furthermore, antigenic restimulation of PBMCs cultured with 2\u2005mg\/dL cBR promoted positive interactions between TNF-\u03b1 and metabolic signaling proteins such as Akt and ERK. Moreover, cBR induced the overproduction of IFN-\u03b3 by CD8+ T cells from individuals with prior HEV exposure and decreased viral titers in both acute and chronic infection models at concentrations greater than or equal to 0.3\u2005mg\/dL. These findings demonstrate that during HEV infection, cBR plays a significant role in modulating the interaction between immune and metabolic components, ultimately influencing viral infectivity.<\/jats:p>","DOI":"10.1093\/jleuko\/qiag078","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:47:47Z","timestamp":1781092067000},"source":"Crossref","is-referenced-by-count":0,"title":["Conjugated bilirubin reduces hepatitis E virus infectivity by modulating immunometabolic processes"],"prefix":"10.1093","volume":"118","author":[{"given":"Javier","family":"Orozco-Cordoba","sequence":"first","affiliation":[{"name":"Departamento de Inmunolog\u00eda, Instituto de Investigaciones Biom\u00e9dicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico , Mexico City 04510 ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio Y","family":"Anaya-Covarrubias","sequence":"additional","affiliation":[{"name":"Departamento de Medicina Gen\u00f3mica en Hepatolog\u00eda, Hospital Civil de Guadalajara Fray Antonio Alcalde, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara , Guadalajara 44280 ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva D","family":"Santiago","sequence":"additional","affiliation":[{"name":"Departamento de Inmunolog\u00eda, Instituto de Investigaciones Biom\u00e9dicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico , Mexico City 04510 ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8185-188X","authenticated-orcid":false,"given":"Diego","family":"Zamora","sequence":"additional","affiliation":[{"name":"Departamento de Inmunolog\u00eda, Instituto de Investigaciones Biom\u00e9dicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico , Mexico City 04510 ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Roman","sequence":"additional","affiliation":[{"name":"Departamento de Medicina Gen\u00f3mica en Hepatolog\u00eda, Hospital Civil de Guadalajara Fray Antonio Alcalde, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara , Guadalajara 44280 ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Panduro","sequence":"additional","affiliation":[{"name":"Departamento de Medicina Gen\u00f3mica en Hepatolog\u00eda, Hospital Civil de Guadalajara Fray Antonio Alcalde, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara , Guadalajara 44280 ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C\u00e9sar","family":"Carrero","sequence":"additional","affiliation":[{"name":"Departamento de Inmunolog\u00eda, Instituto de Investigaciones Biom\u00e9dicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico , Mexico City 04510 ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9719-4838","authenticated-orcid":false,"given":"Nora A","family":"Fierro","sequence":"additional","affiliation":[{"name":"Departamento de Inmunolog\u00eda, Instituto de Investigaciones Biom\u00e9dicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico , Mexico City 04510 ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"2026062905114574600_qiag078-B1","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/liv.14468","article-title":"The global epidemiology of hepatitis E virus infection: a systematic review and meta-analysis","volume":"40","author":"Li","year":"2020","journal-title":"Liver Int"},{"key":"2026062905114574600_qiag078-B2","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/v15071558","article-title":"The re-emergence of hepatitis E virus in Europe and vaccine development","volume":"15","author":"Zahmanova","year":"2023","journal-title":"Viruses"},{"key":"2026062905114574600_qiag078-B3","doi-asserted-by":"publisher","first-page":"S196","DOI":"10.3350\/cmh.2024.0758","article-title":"Hepatitis E as a trigger for acute-on-chronic liver failure","volume":"31","author":"Buti","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"2026062905114574600_qiag078-B4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12985-024-02470-3","article-title":"From discovery to treatment: tracing the path of hepatitis E virus","volume":"21","author":"Letafati","year":"2024","journal-title":"Virol J"},{"key":"2026062905114574600_qiag078-B5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1089\/vim.2023.0096","article-title":"Viral biology and immune privilege in the development of extrahepatic manifestations during hepatitis E virus infection","volume":"36","author":"Orozco-Cordoba","year":"2023","journal-title":"Viral Immunol"},{"key":"2026062905114574600_qiag078-B6","doi-asserted-by":"publisher","first-page":"101491","DOI":"10.1016\/j.coviro.2025.101491","article-title":"Virological and immunological determinants of hepatitis E virus infection outcomes","volume":"73","author":"Wang","year":"2025","journal-title":"Curr Opin Virol"},{"key":"2026062905114574600_qiag078-B7","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1038\/s41598-019-42737-2","article-title":"New insights into the ORF2 capsid protein, a key player of the hepatitis E virus lifecycle","volume":"9","author":"Ankavay","year":"2019","journal-title":"Sci Rep"},{"key":"2026062905114574600_qiag078-B8","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13379","article-title":"Hepatitis E virus egress and beyond\u2014the manifold roles of the viral ORF3 protein","volume":"23","author":"Glitscher","year":"2021","journal-title":"Cell Microbiol"},{"key":"2026062905114574600_qiag078-B9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.biochi.2017.05.003","article-title":"Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response","volume":"141","author":"Chapuy-Regaud","year":"2017","journal-title":"Biochimie"},{"key":"2026062905114574600_qiag078-B10","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/jgh3.12646","article-title":"Hepatitis E: genotypes, strategies to prevent and manage, and the existing knowledge gaps","volume":"5","author":"Kamani","year":"2021","journal-title":"JGH Open"},{"key":"2026062905114574600_qiag078-B11","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41575-024-00950-z","article-title":"Hepatitis E virus: from innate sensing to adaptive immune responses","volume":"21","author":"Br\u00fcggemann","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026062905114574600_qiag078-B12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s10875-010-9506-2","article-title":"Gene expression profiles of T cells from hepatitis E virus infected patients in acute and resolving phase","volume":"31","author":"Trehanpati","year":"2011","journal-title":"J Clin Immunol"},{"key":"2026062905114574600_qiag078-B13","doi-asserted-by":"publisher","first-page":"e603","DOI":"10.1111\/j.1365-2893.2011.01489.x","article-title":"Effector T cells immune reactivity among patients with acute hepatitis E","volume":"18","author":"Husain","year":"2011","journal-title":"J Viral Hepat"},{"key":"2026062905114574600_qiag078-B14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1440-1746.2010.06356.x","article-title":"Adaptive immune responses during acute uncomplicated and fulminant hepatitis E","volume":"26","author":"Srivastava","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"2026062905114574600_qiag078-B15","doi-asserted-by":"publisher","first-page":"6027361","DOI":"10.1155\/2020\/6027361","article-title":"Th1\/Th2 cells and associated cytokines in acute hepatitis E and related acute liver failure","volume":"2020","author":"Wu","year":"2020","journal-title":"J Immunol Res"},{"key":"2026062905114574600_qiag078-B16","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/hep.28819","article-title":"Characterization of the specificity, functionality, and durability of host T-cell responses against the full-length hepatitis E virus","volume":"64","author":"Brown","year":"2016","journal-title":"Hepatology"},{"key":"2026062905114574600_qiag078-B17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"key":"2026062905114574600_qiag078-B18","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/jmv.27669","article-title":"Dynamic changes of serum metabolites associated with infection and severity of patients with acute hepatitis E infection","volume":"94","author":"Wu","year":"2022","journal-title":"J Med Virol"},{"key":"2026062905114574600_qiag078-B19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.molmed.2023.01.007","article-title":"The physiology of bilirubin: health and disease equilibrium","volume":"29","author":"Vitek","year":"2023","journal-title":"Trends Mol Med"},{"key":"2026062905114574600_qiag078-B20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.14218\/jcth.2024.00156","article-title":"The multifaceted role of bilirubin in liver disease: a literature review","volume":"12","author":"Ram\u00edrez-Mej\u00eda","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"2026062905114574600_qiag078-B21","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2015.37","article-title":"Rethinking the immune properties of bilirubin in viral hepatitis: from bench to bedside","volume":"4","author":"Corral-Jara","year":"2015","journal-title":"Clin Transl Immunol"},{"key":"2026062905114574600_qiag078-B22","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.4049\/jimmunol.181.3.1887","article-title":"Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis","volume":"181","author":"Liu","year":"2008","journal-title":"J Immunol"},{"key":"2026062905114574600_qiag078-B23","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1759027","article-title":"Conjugated bilirubin differentially regulates CD4+ T effector cells and T regulatory cell function through outside-in and inside-out mechanisms: the effects of HAV cell surface receptor and intracellular signaling","volume":"2016","author":"Corral-Jara","year":"2016","journal-title":"Mediators Inflamm"},{"key":"2026062905114574600_qiag078-B24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1096\/fj.03-0839fje","article-title":"Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts","volume":"18","author":"Yamashita","year":"2004","journal-title":"FASEB J"},{"key":"2026062905114574600_qiag078-B25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3727\/096368909X484680","article-title":"Bilirubin promotes de novo generation of T regulatory cells","volume":"19","author":"Rocuts","year":"2010","journal-title":"Cell Transplant"},{"key":"2026062905114574600_qiag078-B26","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.molmed.2016.07.004","article-title":"A novel perspective on the biology of bilirubin in health and disease","volume":"22","author":"Gazzin","year":"2016","journal-title":"Trends Mol Med"},{"key":"2026062905114574600_qiag078-B27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1189\/jlb.0211070","article-title":"Immunomodulatory and immunotoxic effects of bilirubin: molecular mechanisms","volume":"90","author":"Khan","year":"2011","journal-title":"J Leukoc Biol"},{"key":"2026062905114574600_qiag078-B28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1042\/bj3200681","article-title":"Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro","volume":"320","author":"Mcphee","year":"1996","journal-title":"Biochem J"},{"key":"2026062905114574600_qiag078-B29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4149\/av_2017_01_86","article-title":"Effects of heme degradation products on reactivation of latent HIV-1","volume":"61","author":"Shankaran","year":"2017","journal-title":"Acta Virol"},{"key":"2026062905114574600_qiag078-B30","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.3892\/mmr.2015.3278","article-title":"Dynamic correlation between induction of the expression of heme oxygenase-1 and hepatitis B viral replication","volume":"11","author":"Shen","year":"2015","journal-title":"Mol Med Rep"},{"key":"2026062905114574600_qiag078-B31","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1002\/hep.23921","article-title":"Biliverdin inhibits hepatitis C virus nonstructural 3\/4A protease activity: mechanism for the antiviral effects of heme oxygenase?","volume":"52","author":"Zhu","year":"2010","journal-title":"Hepatology"},{"key":"2026062905114574600_qiag078-B32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3390\/vaccines12070719","article-title":"Progress and challenges to hepatitis E vaccine development and deployment","volume":"12","author":"Huang","year":"2024","journal-title":"Vaccines (Basel)."},{"key":"2026062905114574600_qiag078-B33","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/pathogens13070578","article-title":"Hepatitis E virus genotype 3 among hemodialysis patients in Mexico: first identification of chronic infection","volume":"13","author":"Copado-Villagrana","year":"2024","journal-title":"Pathogens"},{"key":"2026062905114574600_qiag078-B34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/imm.12336","article-title":"Conjugated bilirubin affects cytokine profiles in hepatitis A virus infection by modulating function of signal transducer and activator of transcription factors","volume":"143","author":"Castro-Garc\u00eda","year":"2014","journal-title":"Immunology"},{"key":"2026062905114574600_qiag078-B35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/vim.2017.0103","article-title":"Conjugated bilirubin upregulates TIM-3 expression on CD4 + CD25+ T cells: anti-inflammatory implications for hepatitis A virus infection","volume":"31","author":"Trujillo-Ochoa","year":"2018","journal-title":"Viral Immunol"},{"key":"2026062905114574600_qiag078-B36","doi-asserted-by":"publisher","first-page":"115481","DOI":"10.1016\/j.celrep.2025.115481","article-title":"Bilirubin metabolism in the liver orchestrates antiviral innate immunity in the body","volume":"44","author":"Du","year":"2025","journal-title":"Cell Rep"},{"key":"2026062905114574600_qiag078-B37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fphar.2012.00036","article-title":"Bilirubin: an endogenous molecule with antiviral activity in vitro","volume":"3","author":"Santangelo","year":"2012","journal-title":"Front Pharmacol"},{"key":"2026062905114574600_qiag078-B38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000492425","article-title":"Hepatitis E virus genotype 1 and hepatitis A virus dual infection in pediatric patients with a low socioeconomic status from Mexico","volume":"61","author":"Realpe-Quintero","year":"2018","journal-title":"Intervirology"},{"key":"2026062905114574600_qiag078-B39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/v8100267","article-title":"Enhanced replication of hepatitis E virus strain 47832c in an A549-derived subclonal cell line","volume":"8","author":"Schemmerer","year":"2016","journal-title":"Viruses"},{"key":"2026062905114574600_qiag078-B40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/v11060483","article-title":"Isolation of subtype 3c, 3e and 3f-like hepatitis E virus strains stably replicating to high viral loads in an optimized cell culture system","volume":"11","author":"Schemmerer","year":"2019","journal-title":"Viruses"},{"key":"2026062905114574600_qiag078-B41","doi-asserted-by":"publisher","first-page":"1189417","DOI":"10.3389\/fcimb.2023.1189417","article-title":"Metabolomics in viral hepatitis: advances and review","volume":"13","author":"Yang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"2026062905114574600_qiag078-B42","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1111\/j.1365-2893.2011.01488.x","article-title":"Metabonomic analysis of hepatitis E patients shows deregulated metabolic cycles and abnormalities in amino acid metabolism","volume":"18","author":"Munshi","year":"2011","journal-title":"J Viral Hepat"},{"key":"2026062905114574600_qiag078-B43","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1089\/vim.2020.0064","article-title":"Evidence for increased inflammatory cytokine profile in hepatitis E virus-infected obese patients: implications for chronic liver disease","volume":"33","author":"Viera-Segura","year":"2020","journal-title":"Viral Immunol"},{"key":"2026062905114574600_qiag078-B44","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jhep.2022.05.019","article-title":"Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection","volume":"77","author":"Kemming","year":"2022","journal-title":"J Hepatol"},{"key":"2026062905114574600_qiag078-B45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1590\/0074-02760140309","article-title":"T-helper 17-related cytokines and IgE antibodies during hepatitis A virus infection in children","volume":"110","author":"Trujillo-Ochoa","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2026062905114574600_qiag078-B46","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00003-19","article-title":"Antiviral candidates for treating hepatitis E virus infection","volume":"63","author":"Netzler","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026062905114574600_qiag078-B47","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/v11060485","article-title":"Hepatitis E virus drug development","volume":"11","author":"Kinast","year":"2019","journal-title":"Viruses"},{"key":"2026062905114574600_qiag078-B48","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/v11070608","article-title":"Cell culture models for hepatitis E virus","volume":"11","author":"Fu","year":"2019","journal-title":"Viruses"},{"key":"2026062905114574600_qiag078-B49","doi-asserted-by":"publisher","first-page":"e00034-21","DOI":"10.1128\/mSphere.00034-21","article-title":"Msphere of influence: apoptotic mimicry and virus entry","volume":"6","author":"Brindley","year":"2021","journal-title":"mSphere"},{"key":"2026062905114574600_qiag078-B50","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00018-023-04977-4","article-title":"The phosphatidylserine receptor TIM1 promotes infection of enveloped hepatitis E virus","volume":"80","author":"Corneillie","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"2026062905114574600_qiag078-B51","doi-asserted-by":"publisher","first-page":"101508","DOI":"10.1016\/j.coviro.2025.101508","article-title":"Beyond the liver: the broadened tissue tropism of hepatitis E virus","volume":"74","author":"Schlienkamp","year":"2026","journal-title":"Curr Opin Virol"},{"key":"2026062905114574600_qiag078-B52","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12967-019-1931-2","article-title":"Prognostic value of TIM-1 expression in human non-small-cell lung cancer","volume":"17","author":"Zheng","year":"2019","journal-title":"J Transl Med"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jleukbio\/advance-article-pdf\/doi\/10.1093\/jleuko\/qiag078\/68512434\/qiag078.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/118\/6\/qiag078\/68512434\/qiag078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/118\/6\/qiag078\/68512434\/qiag078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:11:56Z","timestamp":1782724316000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/doi\/10.1093\/jleuko\/qiag078\/8706272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,8]]}},"URL":"https:\/\/doi.org\/10.1093\/jleuko\/qiag078","relation":{},"ISSN":["1938-3673"],"issn-type":[{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6]]},"article-number":"qiag078"}}